STAT3: A key regulator in liver fibrosis

Ann Hepatol. 2021 Mar-Apr:21:100224. doi: 10.1016/j.aohep.2020.06.010. Epub 2020 Jul 21.

Abstract

Janus protein tyrosine kinase (JAK) has the ability to activate signal transducer and activator of transcription (STAT). STAT3 is a valued member of the JAK/STAT signaling pathway. In recent years, several studies have documented that STAT3 is closely related to the occurrence and development of liver fibrosis caused by various factors. Activation of STAT3 can play anti- or pro-inflammatory roles in the pathogenesis of liver fibrosis. This article reviewed the recent studies on STAT3 in the development of various liver fibrosis to find a more effective method to relieve and cure liver diseases, such as hepatitis B virus (HBV), non-alcoholic fatty liver disease (NAFLD), schistosomiasis, and chemical liver injury.

Keywords: Chemical Liver injury; HBV; Liver fibrosis; NAFLD; STAT3; Schistosomiasis.

Publication types

  • Review

MeSH terms

  • DNA / genetics*
  • Gene Expression Regulation*
  • Humans
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / genetics*
  • Liver Cirrhosis / metabolism
  • STAT3 Transcription Factor / biosynthesis
  • STAT3 Transcription Factor / genetics*
  • Signal Transduction

Substances

  • STAT3 Transcription Factor
  • STAT3 protein, human
  • DNA